{"id":45086,"date":"2019-04-05T14:09:47","date_gmt":"2019-04-05T12:09:47","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=45086"},"modified":"2019-04-05T14:09:47","modified_gmt":"2019-04-05T12:09:47","slug":"farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/","title":{"rendered":"Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat"},"content":{"rendered":"<p>El passat 6 de mar\u00e7 va tenir lloc al COFB la jornada\u00a0<strong>&#8220;Maneig del pacient diab\u00e8tic amb obesitat&#8221;\u00a0<\/strong>en qu\u00e8 es van abordar, entre d&#8217;altres, els <strong>nous reptes<\/strong> en la gesti\u00f3 de pacients amb diabetis, els conceptes de\u00a0<strong>prediabetis<\/strong> i <strong>obesitat<\/strong>, els <strong>objectius terap\u00e8utics en el pacient diab\u00e8tic<\/strong> i la <strong>gesti\u00f3 nutricional<\/strong> i els <strong>h\u00e0bits de vida<\/strong>. La formaci\u00f3 es dirigia a farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria.<\/p>\n<p>Els encarregats d&#8217;impartir-la van ser<strong> Mar Blanco<\/strong>, farmac\u00e8utica comunit\u00e0ria i consultora aliment\u00e0ria; <strong>Xavier Cos<\/strong>, metge d&#8217;Atenci\u00f3 Prim\u00e0ria i president de la <em>Primary Care Diabetes Europe (PCDE)<\/em>; <strong>Diego Mena<\/strong>, farmac\u00e8utic especialista en farm\u00e0cia hospital\u00e0ria i t\u00e8cnic de la Ger\u00e8ncia d&#8217;Harmonitzaci\u00f3 Farmacoterap\u00e8utica del Servei Catal\u00e0 de la Salut (CatSalut) i <strong>Josep Vidal<\/strong>, endocrin\u00f2leg del Servei d&#8217;Endocrinologia i Nutrici\u00f3 de l&#8217;Hospital Cl\u00ednic de Barcelona i director de l&#8217;Institut de Malalties Digestives i Metab\u00f2liques del mateix hospital.<\/p>\n<figure id=\"attachment_45105\" aria-describedby=\"caption-attachment-45105\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190306-09.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-45105 size-large\" title=\"D'esquerra a dreta: Josep Vidal, Roser Vall\u00e8s, Mar Blanco, Xavier Cos i Diego Mena. \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190306-09-1024x683.jpg\" alt=\"D'esquerra a dreta: Josep Vidal, Roser Vall\u00e8s, Mar Blanco, Xavier Cos i Diego Mena. \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-45105\" class=\"wp-caption-text\">D&#8217;esquerra a dreta: Josep Vidal, Roser Vall\u00e8s, Mar Blanco, Xavier Cos i Diego Mena.<\/figcaption><\/figure>\n<p>A trav\u00e9s de la<strong> reflexi\u00f3 conjunta<\/strong> d&#8217;aquests especialistes amb <strong>punts de vista diversos<\/strong> sobre les <strong>estrat\u00e8gies de prevenci\u00f3<\/strong>, <strong>control<\/strong> i <strong>tractament<\/strong> de la diabetis i l&#8217;obesitat es va donar resposta a q\u00fcestions com:<\/p>\n<ul>\n<li>Quina \u00e9s la <strong>millor estrat\u00e8gia a seguir<\/strong> en el tractament i l&#8217;abordatge de l&#8217;obesitat en pacients diab\u00e8tics?<\/li>\n<li>Per qu\u00e8 \u00e9s important el <strong>control de pes<\/strong> en aquest tipus de pacients?\u00a0\u00c9s m\u00e9s dif\u00edcil <strong>controlar el pes<\/strong> en el pacient diab\u00e8tic?<\/li>\n<\/ul>\n<p>Tot plegat, amb l&#8217;objectiu d&#8217;<strong>aprofundir en el coneixement dels nous reptes de la salut dels pacients amb diabetis<\/strong>, saber encarar la gesti\u00f3 nutricional del pacient ob\u00e8s i prediab\u00e8tic i saber utilitzar les estrat\u00e8gies de tractament de l&#8217;obesitat del pacient diab\u00e8tic.<\/p>\n<div class=\"box info\"><\/p>\n<p>La <strong>s\u00edndrome metab\u00f2lica i l&#8217;obesitat abdominal<\/strong> constitueixen un problema creixent de salut, sovint lligat a la <strong>diabetis<\/strong> (i a la intoler\u00e0ncia a la glucosa). A difer\u00e8ncia del teixit subcutani, el dip\u00f2sit de greix intraabdominal activa una s\u00e8rie de mecanismes nocius com s\u00f3n alliberar marcadors inflamatoris que contribueixen a produir una incid\u00e8ncia elevada de malaltia cardiovascular i obesitat en aquests pacients.<\/p>\n<p>La <strong>inflamaci\u00f3<\/strong> \u00e9s un <strong>factor important<\/strong> de l&#8217;obesitat, la <strong>s\u00edndrome metab\u00f2lica<\/strong> i la <strong>diabetis<\/strong>, ja que no \u00fanicament contribueix a produir aquests trastorns, sin\u00f3 que tamb\u00e9 n&#8217;\u00e9s un vincle.<\/p>\n<p><\/div>\n<p>La jornada va comptar amb <strong>4 blocs principals<\/strong>, que resumim tot seguit.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Prediabetis<\/strong><\/span><\/h1>\n<p>En aquest bloc es van abordar les raons per les quals es recomana intervenir en <strong>prediabetis<\/strong> (un factor de risc de desenvolupar <em>Diabetis Mellitus<\/em>) i va citar, entre d&#8217;altres, un estudi que explicava l&#8217;associaci\u00f3 entre la <strong>prediabetis<\/strong> i el risc de <strong>malaltia cardiovascular<\/strong>. Des del\u00a0 punt de vista dels ponents, en prediabetis cal &#8220;<strong>mantenir i potenciar les mesures no farmacol\u00f2giques independentment d&#8217;altres intervencions&#8221;<\/strong>.<\/p>\n<p>Dins d&#8217;aquest primer bloc, tamb\u00e9 es va <strong>donar import\u00e0ncia<\/strong> a l&#8217;<strong>estil de vida saludable<\/strong>.\u00a0Concretament, es va exposar un <a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1800389\" target=\"_blank\" rel=\"noopener\">estudi de Predimed<\/a> fet en persones amb alt risc cardiovascular (sense malaltia cardiovascular) i amb risc de<em> Diabetis Mellitus<\/em> tipus 2 o almenys tres dels seg\u00fcents factors de risc principals: fumar, HTA, sobrep\u00e8s o obesitat, hist\u00f2ria familiar de malaltia cardiovascular, nivells de colesterol, lipoprote\u00efnes elevades de baixa densitat.<\/p>\n<p>Els participants van rebre <strong>sessions educatives trimestrals<\/strong> i la <strong>incid\u00e8ncia d&#8217;ictus, infarts, etc. va ser menor entre els assignats a una dieta mediterr\u00e0nia complementada amb oli d&#8217;oliva verge extra o fruits secs (avellanes, ametlles, nous) que entre aquells que tenien una dieta de control baixa en greixos.\u00a0<\/strong>En aquest apartat tamb\u00e9 hi va haver espai per l&#8217;exposici\u00f3 de treballs centrats en els <strong>beneficis de l&#8217;exercici f\u00edsic<\/strong> en <em>Diabets Mellitus<\/em> tipus 2.<\/p>\n<figure id=\"attachment_45106\" aria-describedby=\"caption-attachment-45106\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190306-18.jpg\"><img decoding=\"async\" class=\"wp-image-45106 size-large\" title=\"L'encarregada de moderar la sessi\u00f3 va ser Roser Vall\u00e8s, vocal d'Atenci\u00f3 Prim\u00e0ria del COFB.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2019\/04\/cofb.190306-18-1024x683.jpg\" alt=\"L'encarregada de moderar la sessi\u00f3 va ser Roser Vall\u00e8s, vocal d'Atenci\u00f3 Prim\u00e0ria del COFB.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-45106\" class=\"wp-caption-text\">L&#8217;encarregada de moderar la sessi\u00f3 va ser Roser Vall\u00e8s, vocal d&#8217;Atenci\u00f3 Prim\u00e0ria del COFB.<\/figcaption><\/figure>\n<h1><span style=\"color: #008080;\"><strong>Adult DM2 (mal control amb estil de vida (EV) + Metformina)<\/strong><\/span><\/h1>\n<p>En aquest segon bloc es van destacar<strong> iniciatives<\/strong> com <a href=\"https:\/\/diabetesalacarta.org\/\" target=\"_blank\" rel=\"noopener\">Diabetis a la carta<\/a>\u00a0un projecte de\u00a0 l&#8217;Institut d&#8217;Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS) i la Fundaci\u00f3 Al\u00edcia <strong>per ajudar als pacients diab\u00e8tics a seguir una alimentaci\u00f3 adequada<\/strong>.<\/p>\n<p>Pel que fa a l&#8217;<strong>exercici aer\u00f2bic recomanat<\/strong>, es va posar de manifest que el volum i la intensitat d&#8217;aquest varien <strong>en funci\u00f3 d&#8217;objectius<\/strong> com: millorar el control gluc\u00e8mic, mantenir un pes corporal adequat i disminuir el risc cardiovascular; reduir el risc cardiovascular en bona part i mantenir a llarg termini una p\u00e8rdua de pes important.<\/p>\n<h1><span style=\"color: #008080;\"><strong>Adult DM2 i fragilitat<\/strong><\/span><\/h1>\n<p>En aquest tercer punt, es va definir la <strong>fragilitat<\/strong> com una s\u00edndrome biol\u00f2gica caracteritzada per la vulnerabilitat als agents estressants de baixa intensitat, la qual cosa condiciona un risc elevat de patir esdeveniments adversos greus com la mort, discapacitat, hospitalitzaci\u00f3, institucionalitzaci\u00f3 i caigudes.<\/p>\n<p>Tamb\u00e9 es va fer refer\u00e8ncia a un <strong>estudi cl\u00ednic que tenia per objectiu avaluar si diferents tipus d&#8217;exercici podien revertir la fragilitat i prevenir la reducci\u00f3 de massa muscular i de la massa \u00f2ssia<\/strong>. D&#8217;altra banda, tamb\u00e9 va exposar com modificar l&#8217;\u00edndex gluc\u00e8mic a trav\u00e9s de l&#8217;alimentaci\u00f3.<\/p>\n<h1><strong><span style=\"color: #008080;\">Adult DM2 i insufici\u00e8ncia card\u00edaca<\/span><\/strong><\/h1>\n<p>Finalment, en l&#8217;\u00faltim dels casos analitzats a la sessi\u00f3, es va fer refer\u00e8ncia a la <strong>insufici\u00e8ncia card\u00edaca<\/strong> i l&#8217;<strong>exercici<\/strong>. Es va destacar la <strong>import\u00e0ncia de fer una avaluaci\u00f3 dels pacients diab\u00e8tics i obesos abans de comen\u00e7ar un programa d&#8217;exercicis<\/strong> i es va posar damunt la taula que l&#8217;exercici -en pacients amb insufici\u00e8ncia card\u00edaca- no nom\u00e9s disminueix la mortalitat sin\u00f3 tamb\u00e9 els reingressos, a m\u00e9s de <strong>millorar la qualitat de vida dels pacients<\/strong>.<\/p>\n<p style=\"text-align: right;\"><strong>Amb el patrocini de:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/www.novonordisk.com\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\" wp-image-37135 alignright\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2018\/02\/novo-nordisk_416x416.jpg\" alt=\"\" width=\"102\" height=\"102\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Altres publicacions d&#8217;inter\u00e8s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/diabetis-malaltia-cardiovascular-mes-enlla-control-glucemia\/\" target=\"_blank\" rel=\"noopener\">Diabetis i malaltia cardiovascular: m\u00e9s enll\u00e0 del control de la gluc\u00e8mia (Febrer 2018)\u00a0<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/mes-de-700-farmaceutics-de-barcelona-ajudaran-detectar-el-risc-de-patir-diabetis-la-campanya-atenciodiabetis\" target=\"_blank\" rel=\"noopener\">M\u00e9s de 700 farmac\u00e8utics de Barcelona ajuden a detectar el risc de patir diabetis a la campanya #Atenci\u00f3Diabetis (Novembre 2017)<\/a><\/li>\n<li><a href=\"http:\/\/blog.cofb.cat\/diabetis-puc-fer-alguna-cosa-per-prevenir-la\/\" target=\"_blank\" rel=\"noopener\">Diabetis: puc fer alguna cosa per prevenir-la (Novembre 2017)<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>El passat 6 de mar\u00e7 va tenir lloc al COFB la jornada\u00a0&#8220;Maneig del pacient diab\u00e8tic amb obesitat&#8221;\u00a0en qu\u00e8 es van abordar, entre d&#8217;altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis, els conceptes de\u00a0prediabetis i obesitat, els objectius terap\u00e8utics en el pacient diab\u00e8tic i la gesti\u00f3 nutricional i [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":45129,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[559,36,938,197,3042,3043,46,2381,3469,2914,264,3470,2385,1013],"class_list":["post-45086","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-activitat-fisica","tag-alimentacio","tag-atencio-primaria","tag-diabetis","tag-estil-de-vida-saludable","tag-exercici-fisic","tag-nutricio","tag-obesitat","tag-pacients-amb-diabetis","tag-prediabetis","tag-prevencio","tag-prevencio-diabetis","tag-prevencio-risc-cardiovascular","tag-vocalia-datencio-primaria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Farmac\u00e8utics d&#039;Atenci\u00f3 Prim\u00e0ria i de l&#039;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs &quot;Maneig del pacient diab\u00e8tic amb obesitat&quot;\u00a0en qu\u00e8 es van abordar, entre d&#039;altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e8utics d&#039;Atenci\u00f3 Prim\u00e0ria i de l&#039;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs &quot;Maneig del pacient diab\u00e8tic amb obesitat&quot;\u00a0en qu\u00e8 es van abordar, entre d&#039;altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-04-05T12:09:47+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat\",\"datePublished\":\"2019-04-05T12:09:47+00:00\",\"dateModified\":\"2019-04-05T12:09:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\"},\"wordCount\":1072,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"activitat f\u00edsica\",\"alimentaci\u00f3\",\"Atenci\u00f3 prim\u00e0ria\",\"diabetis\",\"estil de vida saludable\",\"exercici f\u00edsic\",\"Nutrici\u00f3\",\"obesitat\",\"pacients amb diabetis\",\"prediabetis\",\"prevenci\u00f3\",\"prevenci\u00f3 diabetis\",\"prevenci\u00f3 risc cardiovascular\",\"Vocalia d'Atenci\u00f3 Prim\u00e0ria\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\",\"name\":\"Farmac\u00e8utics d'Atenci\u00f3 Prim\u00e0ria i de l'Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2019-04-05T12:09:47+00:00\",\"dateModified\":\"2019-04-05T12:09:47+00:00\",\"description\":\"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs \\\"Maneig del pacient diab\u00e8tic amb obesitat\\\"\u00a0en qu\u00e8 es van abordar, entre d'altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e8utics d'Atenci\u00f3 Prim\u00e0ria i de l'Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs \"Maneig del pacient diab\u00e8tic amb obesitat\"\u00a0en qu\u00e8 es van abordar, entre d'altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/","og_locale":"ca_ES","og_type":"article","og_title":"Farmac\u00e8utics d'Atenci\u00f3 Prim\u00e0ria i de l'Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs \"Maneig del pacient diab\u00e8tic amb obesitat\"\u00a0en qu\u00e8 es van abordar, entre d'altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.","og_url":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2019-04-05T12:09:47+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat","datePublished":"2019-04-05T12:09:47+00:00","dateModified":"2019-04-05T12:09:47+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/"},"wordCount":1072,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage"},"thumbnailUrl":"","keywords":["activitat f\u00edsica","alimentaci\u00f3","Atenci\u00f3 prim\u00e0ria","diabetis","estil de vida saludable","exercici f\u00edsic","Nutrici\u00f3","obesitat","pacients amb diabetis","prediabetis","prevenci\u00f3","prevenci\u00f3 diabetis","prevenci\u00f3 risc cardiovascular","Vocalia d'Atenci\u00f3 Prim\u00e0ria"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/","url":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/","name":"Farmac\u00e8utics d'Atenci\u00f3 Prim\u00e0ria i de l'Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-04-05T12:09:47+00:00","dateModified":"2019-04-05T12:09:47+00:00","description":"El passat 6 de mar\u00e7 va tenir lloc al COFB el curs \"Maneig del pacient diab\u00e8tic amb obesitat\"\u00a0en qu\u00e8 es van abordar, entre d'altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis o els conceptes de\u00a0prediabetis i obesitat.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2019\/04\/05\/farmaceutics-datencio-primaria-i-de-ladministracio-sanitaria-aprofundeixen-en-el-maneig-del-pacient-diabetic-amb-obesitat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e8utics d&#8217;Atenci\u00f3 Prim\u00e0ria i de l&#8217;Administraci\u00f3 Sanit\u00e0ria aprofundeixen en el maneig del pacient diab\u00e8tic amb obesitat"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 6 de mar\u00e7 va tenir lloc al COFB la jornada\u00a0&#8220;Maneig del pacient diab\u00e8tic amb obesitat&#8221;\u00a0en qu\u00e8 es van abordar, entre d&#8217;altres, els nous reptes en la gesti\u00f3 de pacients amb diabetis, els conceptes de\u00a0prediabetis i obesitat, els objectius terap\u00e8utics en el pacient diab\u00e8tic i la gesti\u00f3 nutricional i [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/45086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=45086"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/45086\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=45086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=45086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=45086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}